Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice

Circulation
S S PatelE T Yeh

Abstract

Monocytes/macrophages play a central role in many stages of development of atherosclerotic plaques, including the conversion to an unstable morphology with rupture and fissuring. A better understanding of the mechanism of attachment of monocytes to activated endothelial cells would prove useful in developing strategies aimed at blocking this initial step. Here we describe a novel in vivo model that directly demonstrates homing of macrophages to atherosclerotic plaques. Macrophages were loaded with fluorescent microspheres and injected intravenously into 40-week-old apolipoprotein E-deficient mice. After 48 hours, labeled macrophages were observed adhering to all stages of atherosclerotic plaques from the early fatty streak to mature calcified lesion. The mean number of macrophages adherent to atherosclerotic plaques located in the proximal 1 mm of the aortic root was quantitated by counting serial frozen sections and found to be 143 +/- 17 macrophages per aortic root. Pretreatment of the apolipoprotein E-deficient mice with monoclonal antibodies directed against the alpha-subunit of the alpha4beta1 integrin and against intracellular cell adhesion molecule (ICAM-1) reduced macrophage homing by 75% and 65%, respectively, as compa...Continue Reading

References

Aug 2, 1990·Nature·T A Springer
Sep 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·R K AssoianM B Sporn
Jan 1, 1988·The International Journal of Biochemistry·L Heickendorff
May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A W BoydJ V Fecondo
Apr 1, 1987·Human Pathology·J M MunroE L Cox
Jan 15, 1997·The Journal of Clinical Investigation·A Varki
Jun 1, 1997·Arthritis and Rheumatism·C F Mojcik, E M Shevach

❮ Previous
Next ❯

Citations

Oct 26, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Philipp Stawowy, Eckart Fleck
Mar 10, 2005·Virchows Archiv : an International Journal of Pathology·Philipp StawowyKristof Graf
May 21, 2008·Current Atherosclerosis Reports·Ahmed Soliman, Patrick Kee
Dec 4, 2003·Atherosclerosis·Alexander Claus LangheinrichWerner Haberbosch
Apr 20, 2004·International Journal of Cardiology·Costas TentolourisChristodoulos Stefanadis
Oct 8, 1999·Clinica Chimica Acta; International Journal of Clinical Chemistry·J DavignonL Bernier
Feb 19, 2002·Atherosclerosis·Kazuo KitagawaMasatsugu Hori
Aug 27, 2003·Metabolism: Clinical and Experimental·Geneviève RenierOmar Serri
Apr 3, 2001·Trends in Cardiovascular Medicine·S LiuM H Ginsberg
Jul 25, 2006·Nature Medicine·Cindy W WongBrenda R Kwak
Jan 13, 2010·Nature Reviews. Cardiology·Kevin J Woollard, Frederic Geissmann
Oct 27, 2001·Acta Physiologica Scandinavica·Y Huo, K Ley
Oct 3, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·P J ManningS D Jones
Dec 19, 2012·Journal of Neuroinflammation·Rachael L TerryNicholas J C King
Jun 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·Filip K SwirskiRalph Weissleder
Feb 25, 2009·Seminars in Immunopathology·Oliver Soehnlein, Christian Weber
May 26, 2001·The Journal of Clinical Investigation·K Ley, Y Huo
Jan 24, 2007·The Journal of Experimental Medicine·Sabrina GrossJean-Etienne Fabre
May 8, 2009·Nanotechnology·Ashwath JayagopalFrederick R Haselton
Aug 23, 2000·Current Cardiology Reports·M V McConnell
Feb 14, 2009·Bulletin of Environmental Contamination and Toxicology·Elizabeth Oesterling OwensBernhard Hennig
Nov 8, 2005·Scandinavian Journal of Clinical and Laboratory Investigation·F MøllerL B Nielsen
Jun 12, 2002·The American Journal of Pathology·Susan M LessnerZorina S Galis
Apr 7, 2009·Biochemical and Biophysical Research Communications·Toru AoyamaToyoaki Murohara
Jul 9, 2008·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Giuseppe FerranteFilippo Crea
Aug 2, 2008·Toxicology and Applied Pharmacology·Elizabeth OesterlingBernhard Hennig
Feb 9, 2012·British Journal of Clinical Pharmacology·Inge De MeyerGuido R Y De Meyer
Dec 21, 2012·European Journal of Immunology·Alain C TissotMartin F Bachmann
Nov 21, 1998·The Journal of Laboratory and Clinical Medicine·Z M Dong, D D Wagner
Jun 5, 2004·Progress in Retinal and Eye Research·Tsutomu YasukawaYoshihito Honda
Jun 3, 2006·Vascular Pharmacology·Florian BlaschkeRonald E Law
May 15, 2013·Clinical Science·Kevin J Woollard
Feb 24, 2009·Current Opinion in Pharmacology·Prakash SahaAlberto Smith

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.